The Cost-Effectiveness Analysis of Rhtpo Versus Il-11 on The Treatment of Chemotherapy-Induced Thrombocytopenia Patients in China
May 1, 2018, 00:00
10.1016/j.jval.2018.04.105
https://www.valueinhealthjournal.com/article/S1098-3015(18)30405-4/fulltext
Title :
The Cost-Effectiveness Analysis of Rhtpo Versus Il-11 on The Treatment of Chemotherapy-Induced Thrombocytopenia Patients in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30405-4&doi=10.1016/j.jval.2018.04.105
First page :
Section Title :
Open access? :
No
Section Order :
429